Apellis Pharmaceuticals
http://apellis.com/Development of novel therapeutic compounds for autoimmune and inflammatory diseases. (NASDAQ: APLS)
Investors 3
Mentions in press and media 11
| Date | Title | Description | Category | Author | Source |
| 11.06.2020 | What being... | On March 14, at 10 a.m., I got... | - | - | statnews.c... |
| 16.03.2020 | Two biotec... | On Friday evening, Allogene CE... | - | - | medcitynew... |
| 14.11.2017 | Epidarex C... | Epidarex Capital, an early-sta... | - | - | citybizlis... |
| 10.11.2017 | Term Sheet... | HOT TAKES Happy Friday, Term ... | - | - | fortune.co... |
| 31.10.2017 | Term Sheet... | DEAD AND GONE Good morning, T... | - | - | fortune.co... |
| 16.10.2017 | Term Sheet... | MONDAY KICKOFF Good morning, ... | - | - | fortune.co... |
| 10.08.2017 | Apellis Ph... | Apellis Pharmaceuticals, Inc.,... | USA | - | finsmes.co... |
| 12.02.2016 | Apellis Ph... | Apellis Pharmaceuticals, Inc.,... | USA | - | finsmes.co... |
| 02.12.2014 | Immunother... | -COPD. Apellis thinks the same... | - | - | medcitynew... |
| 05.04.2013 | Move over ... | Bob Saunders, an angel investo... | - | - | medcitynew... |
Show more